COMAT Emergency Medicine Practice Test

For a patient with symptomatic bradycardia, the administration of atropine is a key initial treatment option. Atropine is an anticholinergic agent that works by blocking the effects of the vagus nerve on the heart, leading to an increase in heart rate. This is particularly effective in cases where bradycardia is caused by increased vagal tone or certain types of heart block.

In symptomatic bradycardia, symptoms can include hypotension, dizziness, syncope, or any signs of decreased cardiac output. The goal of treatment is to alleviate these symptoms and stabilize the patient. Atropine is typically given intravenously and can provide rapid relief, making it an appropriate first-line therapy.

Utilizing pacing may be necessary in cases where atropine is ineffective or in specific situations such as advanced heart block or when the patient remains unstable after atropine administration. While cardioversion is crucial for certain arrhythmias like atrial fibrillation or flutter with a rapid ventricular response, it does not apply to bradycardia management directly. Observation alone would not adequately address the symptomatic nature of the bradycardia and could risk further deterioration of the patient’s condition.